Vestcor Inc grew its position in shares of Cencora, Inc. (NYSE:COR – Free Report) by 373.1% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 24,580 shares of the company’s stock after purchasing an additional 19,384 shares during the period. Vestcor Inc’s holdings in Cencora were worth $8,302,000 at the end of the most recent quarter.
Several other hedge funds also recently modified their holdings of COR. JFS Wealth Advisors LLC boosted its position in shares of Cencora by 30.2% in the fourth quarter. JFS Wealth Advisors LLC now owns 125 shares of the company’s stock worth $42,000 after acquiring an additional 29 shares during the last quarter. Apollon Wealth Management LLC boosted its position in shares of Cencora by 0.5% in the fourth quarter. Apollon Wealth Management LLC now owns 6,527 shares of the company’s stock worth $2,205,000 after acquiring an additional 30 shares during the last quarter. Accent Capital Management LLC boosted its position in shares of Cencora by 36.1% in the fourth quarter. Accent Capital Management LLC now owns 113 shares of the company’s stock worth $38,000 after acquiring an additional 30 shares during the last quarter. MCF Advisors LLC boosted its position in shares of Cencora by 11.0% in the fourth quarter. MCF Advisors LLC now owns 303 shares of the company’s stock worth $102,000 after acquiring an additional 30 shares during the last quarter. Finally, CYBER HORNET ETFs LLC boosted its position in shares of Cencora by 6.8% in the fourth quarter. CYBER HORNET ETFs LLC now owns 485 shares of the company’s stock worth $164,000 after acquiring an additional 31 shares during the last quarter. 97.52% of the stock is owned by institutional investors and hedge funds.
Wall Street Analyst Weigh In
Several research firms recently issued reports on COR. JPMorgan Chase & Co. raised their target price on shares of Cencora from $417.00 to $419.00 and gave the stock an “overweight” rating in a research report on Tuesday, February 10th. Evercore set a $360.00 price target on shares of Cencora in a research report on Wednesday, April 8th. William Blair began coverage on shares of Cencora in a research report on Tuesday, April 28th. They set a “market perform” rating on the stock. Leerink Partners reaffirmed an “outperform” rating on shares of Cencora in a research report on Tuesday, March 17th. Finally, UBS Group lifted their price target on shares of Cencora from $410.00 to $412.00 and gave the company a “buy” rating in a research report on Thursday, May 7th. Twelve equities research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company’s stock. According to MarketBeat, Cencora currently has an average rating of “Moderate Buy” and a consensus target price of $380.25.
Cencora Trading Up 1.7%
Shares of COR stock opened at $274.94 on Friday. The stock has a market cap of $53.49 billion, a price-to-earnings ratio of 21.08, a price-to-earnings-growth ratio of 1.46 and a beta of 0.59. The company has a quick ratio of 0.59, a current ratio of 0.95 and a debt-to-equity ratio of 3.40. Cencora, Inc. has a fifty-two week low of $244.82 and a fifty-two week high of $377.54. The firm’s 50 day moving average price is $292.70 and its two-hundred day moving average price is $330.55.
Cencora (NYSE:COR – Get Free Report) last posted its quarterly earnings data on Wednesday, May 6th. The company reported $4.75 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $4.82 by ($0.07). The firm had revenue of $78.36 billion for the quarter, compared to analysts’ expectations of $81.09 billion. Cencora had a net margin of 0.78% and a return on equity of 135.20%. The company’s revenue for the quarter was up 3.9% on a year-over-year basis. During the same quarter in the prior year, the business earned $4.42 EPS. Cencora has set its FY 2026 guidance at 17.650-17.900 EPS. On average, analysts anticipate that Cencora, Inc. will post 17.79 EPS for the current year.
Cencora Dividend Announcement
The company also recently disclosed a quarterly dividend, which was paid on Monday, June 1st. Stockholders of record on Friday, May 15th were paid a dividend of $0.60 per share. The ex-dividend date was Friday, May 15th. This represents a $2.40 dividend on an annualized basis and a dividend yield of 0.9%. Cencora’s dividend payout ratio (DPR) is currently 18.40%.
Cencora announced that its board has initiated a share repurchase plan on Thursday, May 21st that permits the company to buyback $2.00 billion in outstanding shares. This buyback authorization permits the company to reacquire up to 3.9% of its stock through open market purchases. Stock buyback plans are typically a sign that the company’s leadership believes its stock is undervalued.
About Cencora
Cencora (NYSE:COR) is a global healthcare services and pharmaceutical distribution company that provides end-to-end solutions across the pharmaceutical supply chain. The company’s core activities include wholesale drug distribution, specialty drug distribution, and the operation of specialty pharmacies, complemented by logistics, cold-chain management and other fulfillment services designed to support complex and temperature-sensitive therapies.
Beyond physical distribution, Cencora offers a range of commercial and patient-focused services for pharmaceutical manufacturers and healthcare providers.
Further Reading
- Five stocks we like better than Cencora
- MarketBeat Week in Review – 06/01 – 06/05
- AI Server Earnings: Wall Street Sees One Clear Standout
- Navitas: NVIDIA’s AI Power Broker?
- A Lulu of a Miss Sends Lululemon to New Lows—Look Out Below
Receive News & Ratings for Cencora Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cencora and related companies with MarketBeat.com's FREE daily email newsletter.
